A look at the science and emerging evidence about Vitamin D’s potential as an anti-viral and in the immune system. Part of our series on Vitamins, Supplements and COVID-19.
Credits for vitamin D and COVID-19. Other credits in comments.
24px-Blausen_0766_Respiratory Epithelium with notes and mods by o’laughlin (no date).
1107px-Monocyte_40x Bobjgalindo, CC BY-SA 4.0 (no date).
Ambulance_in_Cayman_Islands_03 ambulance. pixabay or wikipedia commons (no date).
Annweiler, G. et al. (2020) ‘Vitamin D Supplementation Associated to Better Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Quasi-Experimental Study’, Nutrients, 12(11), p. 3377. doi: 10.3390/nu12113377.
Biancuzzo, R. M. et al. (2013) ‘Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation’, The Journal of Clinical Endocrinology and Metabolism, 98(3), pp. 973–979. doi: 10.1210/jc.2012-2114.
Botelho, J. et al. (2020) ‘Vitamin D Deficiency and Oral Health: A Comprehensive Review’, Nutrients, 12(5), p. 1471. doi: 10.3390/nu12051471.
‘Cathelicidin’ (2021) Wikipedia.
Crane-Godreau, M. A. et al. (2020a) ‘Vitamin D Deficiency and Air Pollution Exacerbate COVID-19 Through Suppression of Antiviral Peptide LL37’, Frontiers in Public Health, 8. doi: 10.3389/fpubh.2020.00232.
Currie, S. M. et al. (2013) ‘The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus’, PLOS ONE, 8(8), p. e73659. doi: 10.1371/journal.pone.0073659.
Duplantier, A. J. and van Hoek, M. L. (2013) ‘The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds’, Frontiers in Immunology, 4. doi: 10.3389/fimmu.2013.00143.
Entrenas Castillo, M. et al. (2020) ‘“Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”’, The Journal of Steroid Biochemistry and Molecular Biology, 203, p. 105751. doi: 10.1016/j.jsbmb.2020.105751.
Fletcher, J. et al. (2019a) ‘The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management’, Nutrients, 11(5), p. 1019. doi: 10.3390/nu11051019.
flight-4759107_1920 credit Image by Chris Engel from Pixabay (no date).
fpubh-08-00232-g001 frontiers in science vit d air polution covid19 Crane Gudreau (no date).
Frontiers | Vitamin D Deficiency and Air Pollution Exacerbate COVID-19 Through Suppression of Antiviral Peptide LL37 | Public Health (no date a).
Gianfrancesco, M. A. et al. (2017) ‘Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS’, Neurology, 88(17), pp. 1623–1629. doi: 10.1212/WNL.0000000000003849.
Gombart, A. F. (2009) ‘The vitamin D–antimicrobial peptide pathway and its role in protection against infection’, Future microbiology, 4, p. 1151. doi: 10.2217/fmb.09.87.
Grant, W. B., Baggerly, C. A. and Lahore, H. (2020) ‘Reply: “Vitamin D Supplementation in Influenza and COVID-19 Infections. Comment on: Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths Nutrients 2020, 12(4), 988”’, Nutrients, 12(6). doi: 10.3390/nu12061620.
‘graphic credit of cathelicidin and ll37 credit to this team of Crane Godreau et al.’ (no date).
Guy’s and St Thomas’ NHS Foundation Trust (2020) Retrospective Pilot Study of Vitamin D Status and Immune-inflammatory Status in Different UK Populations With COVID-19 Infection. Clinical trial registration NCT04519034. clinicaltrials.gov.
Gysin, D. V. et al. (2016) ‘Effect of Vitamin D3 Supplementation on Respiratory Tract Infections in Healthy Individuals: A Systematic Review and Meta-Analysis of Randomized Controlled Trials’, PLOS ONE, 11(9), p. e0162996. doi: 10.1371/journal.pone.0162996.
Häusler, D. and Weber, M. S. (2019) ‘Vitamin D Supplementation in Central Nervous System Demyelinating Disease—Enough Is Enough’, International Journal of Molecular Sciences, 20(1), p. 218. doi: 10.3390/ijms20010218.
Hernández, J. L. et al. (2020) ‘Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection’, The Journal of Clinical Endocrinology & Metabolism, (dgaa733). doi: 10.1210/clinem/dgaa733.
Hewison, M. (2012b) ‘Vitamin D and immune function: an overview’, Proceedings of the Nutrition Society, 71(1), pp. 50–61. doi: 10.1017/S0029665111001650.
Hussein, Y. A. A. (2021) Impact of Vitamin D Level and Supplement on SLE Patients During COVID-19 Pandemic. Clinical trial registration NCT04709744. clinicaltrials.gov. Available at: (Accessed: 21 January 2021).
Ilie, P. C., Stefanescu, S. and Smith, L. (2020) ‘The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality’, Aging Clinical and Experimental Research, 32(7), pp. 1195–1198. doi: 10.1007/s40520-020-01570-8.
